Skip to search formSkip to main contentSkip to account menu

brequinar

Known as: 6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid, 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid, Bipenquinate 
A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
  • Corpus ID: 54912504
A preparation comprising a compound which essentially prevents the enterohepatic circulation of nucleotide Synthe sis inhibitors… 
1997
1997
A imunossupressao clinica foi iniciada no comeco dos anos 50 com o uso de glicocorticoides associados a azatioprina e/ou… 
1997
1997
Immunosuppressive drugs are agents capable of modulating at least one type of immune response in vivo at doses with tolerable… 
Review
1995
Review
1995
With the advent of cyclosporine in the 1980s, transplantation has become the treatment of choice for many end-stage organ… 
1994
1994
Mit der Entwicklung mehrerer neuer immunosuppressiver Substanzen in der letzten Zeit ist die medikamentose Therapie nach… 
1994
1994
(57) Abstract: The present invention is an antibody specific to quinolinecarboxylic acid for example brequinar, the joint as a… 
1990
1990
Exposure of mouse L1210 leukemia cells to 25 microM brequinar for 4 h results in large accumulations of N-carbamyl-L-aspartate…